Use of Names; Publicity Sample Clauses

Use of Names; Publicity. The Trust shall not use the Distributor’s name in any offering material, shareholder report, advertisement or other material relating to the Trust, in a manner not approved by the Distributor in writing prior to such use, such approval not to be unreasonably withheld. The Distributor hereby consents to all uses of its name required by the SEC, any state securities commission, or any federal or state regulatory authority. The Distributor shall not use the name “__________” in any offering material, shareholder report, advertisement or other material relating to the Distributor, other than for the purpose of merely identifying the Trust as a client of Distributor hereunder, in a manner not approved by the Trust in writing prior to such use; provided, however, that the Trust shall consent to all uses of its name required by the SEC, any state securities commission, or any federal or state regulatory authority; and provided, further, that in no case shall such approval be unreasonably withheld. The Distributor will not issue any press releases or make any public announcements regarding the existence of this Agreement without the express written consent of the Trust. Neither the Trust nor the Distributor will disclose any of the economic terms of this Agreement, except as may be required by law.
Use of Names; Publicity. Any Member may disclose and publicize such Member’s membership in the Foundation, within guidelines proposed by the Foundation as set forth in the Bylaws. As a new member to the Foundation, Member agrees to publicly announce joining the Foundation and to provide a logo for the Foundation’s use in recognizing membership.
Use of Names; Publicity. Except to the extent required by applicable law or regulation or the rules of any stock exchange or listing agency, no party will use the name of another party in any form of advertising, promotion or publicity or in any press release, without the prior written consent of that other party. MSK and Investigator-Sponsor agree not to answer inquiries regarding the Study or the Study Drug Product from financial analysts.
Use of Names; Publicity. Except as otherwise provided herein, nothing contained in this Agreement shall be construed as conferring any right on Receiving Party to use in any manner Disclosing Party’s name or any trade name or trademark. Receiving Party will make no public announcement or other public statement concerning the existence of this Agreement or the Parties’ respective performances hereunder without the prior written consent of Disclosing Party, which may be withheld in Disclosing Party’s sole and absolute discretion, except as necessary to comply with applicable law or regulations.
Use of Names; Publicity. Neither Party shall use the name, seal, logo, trademark, or service mark of the other or any of its personnel, or any adaptation thereof, in any advertising, promotional, or sales literature without prior written consent obtained from the other Party. Either Party may publicize the fact that the Parties have entered in to this Agreement. However, press releases or other public releases of information shall be coordinated between the Parties prior to release.
Use of Names; Publicity. Except to the extent required by Applicable Law, no party will use the name of another party in any form of advertising, promotion or publicity or in any press release, without the prior written consent of that other party. Institution and Investigator expressly consent to Sponsor’s listing of information about the Trial on publicly accessible internet sites (for example, ClinicalTrials.gov, patient recruitment sites, etc.), including the name and contact information for Institution and/or Investigator. 13.
Use of Names; Publicity. Consultant shall not use Akebia’s name or the name of its employees or consultants in any advertising, sales or promotional material and Consultant shall not originate any publicity, news release, or other public announcement, written or oral, whether to the public press or otherwise, relating to this Agreement or to performance of the Services hereunder without Akebia’s prior written consent.
Use of Names; Publicity. Except as set forth herein, neither party shall use the other party’s name, logo, service marks, domain names, symbols or any other name or mark belonging to a party without the other party’s prior written consent which shall not be unreasonably withheld, other than in providing the Services to TPA under this Agreement. Vaccine Provider may not use TPA as a reference or this Agreement as an endorsement of Vaccine Provider’s work without TPA’s prior written consent. The parties will cooperate to create any and all appropriate public, promotional announcements or press releases relating to the relationship set forth in this Agreement. Neither party shall make any public announcement regarding the existence or content of this Agreement without the other party’s prior written approval and consent. Notwithstanding the foregoing, Vaccine Provider understands and expressly consents to TPA’s use of Vaccine Provider’s name, logo, service marks, domain names, symbols, vaccination site addresses and contact information, or any other Vaccine Provider name or mark for purposes of the State’s vaccination appointment system (currently identified as MyTurn) and related communications.
Use of Names; Publicity. Except as required by law, neither party shall use the name of the other party or any of their respective officers, employees, consultants, or agents in any press release, promotional material or other publicity without the prior written consent of the other party, which consent will not be unreasonably withheld, delayed or conditioned.